14
24
32
eEdition: April 2025- Issue 4- Volume 6
CHIEF EDITOR Rahul Koul
EDITORIAL Sachin Arya Special Correspondent
Vaishnavi Srivastava Reporter
Brijesh Kumar News Desk
Shanu K Art Direction & Cartoon
BUSINESS HEAD Bhaskar Jha
OPERATIONS Arvind Kumar Executive Oprations
Barun Dey Admin Executive
For advertinsing & marketing write to us: advertising @ biovoicenews. com
Disclaimer: Views and opinions expressed in this e- magazine are not necessarily those of BioVoice News and its publisher PetriDish Media Pvt. Ltd. and / or editors. We, at PetriDish Media Pvt. Ltd. do our best to verify the information published, but do not take responsibility for the absolute accuracy of the information contained in this publication. PetriDish Media Pvt. Ltd. does not accept responsibility for any business or any other decisions taken by the readers on the basis of the information provided herein. All rights reserved. No part of this publication should be reproduced by any means without the written permission from the publisher. Published by: PetriDish Media Pvt. Ltd., B-1 / 6, LGF, Hauz Khas, New Delhi – 110016, INDIA
14
24
32
COVER STORY
INDIA’ S NEXT BIOPHARMA BOOM
Biosimilars industry eyes a billion-dollar windfall
The biopharmaceutical industry is entering a significant transformation phase as numerous blockbuster biologic drugs approach their patent expiration globally. This transition opens up vast opportunities for countries with strong pharmaceutical capabilities, and India stands to benefit immensely. We explore the scale of the patent expiry wave, its implications for the global market, and how the Indian pharmaceutical industry can position itself as a dominant player in the biosimilars and biopharma space.
INTERVIEW
“ Patent expiry of significant number of biologics by 2030 is a huge opportunities for biosimilars players”
In an exclusive interview, Dr Cyrus Karkaria, President-Biotechnology, Lupin Limited shares his views on the current market trends and growth prospects of Indian biosimilars industry, company’ s key offerings, ongoing initiatives, and future plans
INTERVIEW
“ Biomanufacturing has shifted focus from just being efficient to staying ahead of the curve” In an exclusive interview, Sachin Joshi, Managing Director & Founder, PharmNXT Biotech shares insights on the company’ s focus on innovation, key product offerings, upcoming initiatives, sustainability and future plans
04
BioVoiceNews | April 2025